Bobak Thomas Pousti

Bobak Pousti practices at San Diego Family Dermatology - National City in National City, California.

Bobak Pousti's NPI, 1932736451, was assigned on March 25, 2020. Bobak Pousti graduated from Lewis Katz School of Medicine in 2020. Bobak Pousti's California license number on file is 1932736451.

Bobak Pousti's primary practice is San Diego Family Dermatology - National City, at 655 Euclid Ave, Ste 304, National City, CA 91950. The practice phone is (619) 267-8303.

Bobak Pousti's primary practice is San Diego Family Dermatology - National City in National City, California. The medical group on file is San Diego Family Dermatology. Dmand AI also links Bobak Pousti to 1 more group practice or clinic, named with a free account. Bobak Pousti's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Bobak Pousti practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Bobak Pousti's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Bobak Pousti is board certified in dermatology by the American Board of Dermatology. Bobak Pousti has a license on file in California.

CMS data shows 355 Medicare services from Bobak Pousti across 8 procedure codes in 2024, for 121 Medicare patients. Medicare paid $18,992 for them. Every service was in an office.

CMS counts 121 Medicare patients who saw Bobak Pousti in 2024. The largest group is 65 to 74, with 50 patients. 69% of them have high cholesterol, and 68% have high blood pressure. 38% are also on Medicaid. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Bobak Pousti's median patient age at 53, with 55% women.

In 2024, Bobak Pousti wrote 310 Medicare Part D claims for 139 patients. 95% of them were for generic drugs. CMS names the drug for 226 of them, across 9 drugs with 11 or more claims each, at $6,434 in total drug cost. In 2023, CMS named 50 claims across 2 drugs.

Bobak Pousti accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 416 procedures of removal of skin lesions by Bobak Pousti, more than 85% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 16 papers to Bobak Pousti, published from 2019 to 2024. 2021 was the busiest year, with 4. The most frequent topics are Antibodies, Monoclonal, Humanized, Skin Neoplasms and Laser Therapy. Bobak Pousti has published most often in Cutis. Bobak Pousti's most frequent co-authors are Nicholas Kian Mollanazar, MBA, MD, Sylvia Hsu, MD and Lambros C. Chrones, MD.

CMS Open Payments shows 43 general payments to Bobak Pousti from 15 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 69% of the total. Abbvie Inc. paid the most, $1,689.

Bobak Pousti graduated from Lewis Katz School of Medicine in 2020.

Bobak Pousti is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.